About Kuros Biosciences
Kuros Biosciences is a company based in Schlieren (Switzerland) founded in 2000.. Kuros Biosciences has raised $24.65 million across 7 funding rounds from investors including Optiver, European Union and Life Sciences Partners. The company has 4 employees as of December 31, 2024. Kuros Biosciences has completed 1 acquisition, including Xpand Biotechnology. Kuros Biosciences offers products and services including MagnetOs, MagnetOs Easypack Putty, MagnetOs Flex Matrix, MagnetOs Putty, and MagnetOs Granules. Kuros Biosciences operates in a competitive market with competitors including OssDsign, ISTO Biologics, BONESUPPORT, Askel Healthcare and Renovos, among others.
- Headquarter Schlieren, Switzerland
- Employees 4 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Kuros Biosciences Ltd.
-
Annual Revenue
$83.4 M (USD)125.11as on Dec 31, 2024
-
Net Profit
$-4.74 M (USD)68.75as on Dec 31, 2024
-
EBITDA
$2.84 M (USD)199.61as on Dec 31, 2024
-
Total Equity Funding
$24.65 M (USD)
in 7 rounds
-
Latest Funding Round
$6.24 M (USD), Post-IPO
Sep 07, 2022
-
Investors
Optiver
& 11 more
-
Employee Count
4
as on Dec 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Kuros Biosciences
Kuros Biosciences is a publicly listed company on the SIX with ticker symbol KURN in Switzerland, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Kuros Biosciences
Kuros Biosciences offers a comprehensive portfolio of products and services, including MagnetOs, MagnetOs Easypack Putty, MagnetOs Flex Matrix, MagnetOs Putty, and MagnetOs Granules. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Promotes bone growth for spinal fusions using advanced surface technology.
Provides flexible bone graft solution for surgical applications.
Enables predictable fusion in spinal procedures.
Supports bone regeneration in soft tissue environments.
Facilitates bone growth for fusion surgeries.
Funding Insights of Kuros Biosciences
Kuros Biosciences has successfully raised a total of $24.65M across 7 strategic funding rounds. The most recent funding activity was a Post-IPO round of $6.24 million completed in September 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Post-IPO — $6.2M
-
First Round
First Round
(06 Oct 2005)
- Investors Count 12
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2022 | Amount | Post-IPO - Kuros Biosciences | Valuation |
investors |
|
| Jan, 2021 | Amount | Grant - Kuros Biosciences | Valuation |
investors |
|
| Jan, 2020 | Amount | Grant - Kuros Biosciences | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Kuros Biosciences
Kuros Biosciences has secured backing from 12 investors, including institutional and venture fund investors. Prominent investors backing the company include Optiver, European Union and Life Sciences Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
LifeCare Partners is involved in unspecified activities.
|
Founded Year | Domain | Location | |
|
Private equity investments in life sciences businesses are managed.
|
Founded Year | Domain | Location | |
|
Early-stage venture capital is invested in US and Europe.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Kuros Biosciences
Kuros Biosciences has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Xpand Biotechnology. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Mini-bioreactors are developed as alternatives to 2D cell culture systems.
|
2004 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Kuros Biosciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Kuros Biosciences Comparisons
Competitors of Kuros Biosciences
Kuros Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as OssDsign, ISTO Biologics, BONESUPPORT, Askel Healthcare and Renovos, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of regenerative 3D-printed orthopedic implants for craniofacial bone defects and trauma
|
|
| domain | founded_year | HQ Location |
Developer of treatments for cartilage and bone problems
|
|
| domain | founded_year | HQ Location |
Injectable synthetic bone substitutes are developed for fracture treatment.
|
|
| domain | founded_year | HQ Location |
Regenerative medicines for cartilage and bone tissue regeneration are developed.
|
|
| domain | founded_year | HQ Location |
Renovos is focused on regenerative medicine and therapeutic delivery.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Kuros Biosciences
Frequently Asked Questions about Kuros Biosciences
When was Kuros Biosciences founded?
Kuros Biosciences was founded in 2000 and raised its 1st funding round 5 years after it was founded.
Where is Kuros Biosciences located?
Kuros Biosciences is headquartered in Schlieren, Switzerland. It is registered at Schlieren, Zurich, Switzerland.
Is Kuros Biosciences a funded company?
Kuros Biosciences is a funded company, having raised a total of $24.65M across 7 funding rounds to date. The company's 1st funding round was a Grant of $488.18K, raised on Oct 06, 2005.
How many employees does Kuros Biosciences have?
As of Dec 31, 2024, the latest employee count at Kuros Biosciences is 4.
What is the annual revenue of Kuros Biosciences?
Annual revenue of Kuros Biosciences is $83.4M as on Dec 31, 2024.
What does Kuros Biosciences do?
Kuros Bioscience is a provider of smart solutions for bone disease management. It has developed solutions to improve patient rehabilitation. It provides a MagnetOs, a unique bone graft with submicron surface topography, that harnesses the power of osteoimmunology to deliver uniform, solid and stable spinal fusions. It has also developed a Fibrin-PTH candidate that delivers targeted and controlled bone formation. It promotes bone formation through the induction of osteoprogenitor cell differentiation, enhancement of osteoblast proliferation and by increasing the lifespan of bone-forming cells. The device is in clinical trial 2A stage FDA approved.
Who are the top competitors of Kuros Biosciences?
Kuros Biosciences's top competitors include BONESUPPORT, OssDsign and Askel Healthcare.
What products or services does Kuros Biosciences offer?
Kuros Biosciences offers MagnetOs, MagnetOs Easypack Putty, MagnetOs Flex Matrix, MagnetOs Putty, and MagnetOs Granules.
Is Kuros Biosciences publicly traded?
Yes, Kuros Biosciences is publicly traded on SIX under the ticker symbol KURN.
How many acquisitions has Kuros Biosciences made?
Kuros Biosciences has made 1 acquisition, including Xpand Biotechnology.
Who are Kuros Biosciences's investors?
Kuros Biosciences has 12 investors. Key investors include Optiver, European Union, Life Sciences Partners, LifeCare Partners, and VIP Partners.
What is Kuros Biosciences's ticker symbol?
The ticker symbol of Kuros Biosciences is KURN on SIX.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.